Hoth Stock Based Compensation vs Change To Liabilities Analysis
HOTH Stock | USD 0.85 0.01 1.16% |
Hoth Therapeutics financial indicator trend analysis is much more than just examining Hoth Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Hoth Therapeutics is a good investment. Please check the relationship between Hoth Therapeutics Stock Based Compensation and its Change To Liabilities accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
Stock Based Compensation vs Change To Liabilities
Stock Based Compensation vs Change To Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Hoth Therapeutics Stock Based Compensation account and Change To Liabilities. At this time, the significance of the direction appears to have very week relationship.
The correlation between Hoth Therapeutics' Stock Based Compensation and Change To Liabilities is 0.23. Overlapping area represents the amount of variation of Stock Based Compensation that can explain the historical movement of Change To Liabilities in the same time period over historical financial statements of Hoth Therapeutics, assuming nothing else is changed. The correlation between historical values of Hoth Therapeutics' Stock Based Compensation and Change To Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Stock Based Compensation of Hoth Therapeutics are associated (or correlated) with its Change To Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Liabilities has no effect on the direction of Stock Based Compensation i.e., Hoth Therapeutics' Stock Based Compensation and Change To Liabilities go up and down completely randomly.
Correlation Coefficient | 0.23 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Change To Liabilities
Most indicators from Hoth Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hoth Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.As of now, Hoth Therapeutics' Selling General Administrative is increasing as compared to previous years. The Hoth Therapeutics' current Enterprise Value Over EBITDA is estimated to increase to 26.71, while Issuance Of Capital Stock is projected to decrease to under 9.4 M.
Hoth Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Hoth Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hoth Therapeutics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.8M | 5.2M | 11.0M | 6.8M | 9.5M | 5.8M | |
Other Current Liab | 36.2K | 182.7K | 506.8K | 692.7K | 585.4K | 347.6K | |
Total Current Liabilities | 440.1K | 312.1K | 867.8K | 1.4M | 678.7K | 641.9K | |
Total Stockholder Equity | 2.4M | 4.6M | 9.9M | 5.1M | 8.8M | 5.1M | |
Net Tangible Assets | 154.7K | 2.4M | 4.6M | 9.9M | 11.4M | 11.9M | |
Net Debt | (1.7M) | (2.6M) | (8.5M) | (6.4M) | (9.2M) | (8.8M) | |
Retained Earnings | (12.2M) | (19.4M) | (33.7M) | (45.1M) | (52.9M) | (50.3M) | |
Accounts Payable | 403.9K | 129.5K | 361.0K | 695.0K | 35.6K | 33.8K | |
Cash | 1.7M | 2.6M | 8.5M | 6.4M | 9.3M | 4.7M | |
Non Current Assets Total | 201.0K | 460K | 410K | 33K | 92.6K | 87.9K | |
Non Currrent Assets Other | 200K | 50K | 0.0 | 33K | (1.0) | (0.95) | |
Cash And Short Term Investments | 2.5M | 4.7M | 10.4M | 6.6M | 9.3M | 5.5M | |
Common Stock Shares Outstanding | 366.6K | 494.5K | 893.2K | 1.2M | 3.4M | 1.8M | |
Liabilities And Stockholders Equity | 2.8M | 5.2M | 11.0M | 6.8M | 9.5M | 5.8M | |
Non Current Liabilities Total | 403.9K | 285K | 235K | 250K | 26.3K | 25.0K | |
Other Stockholder Equity | 14.6M | 24.1M | 43.6M | 50.2M | 61.7M | 31.8M | |
Total Liab | 440.1K | 597.1K | 1.1M | 1.6M | 705.0K | 767.0K | |
Net Invested Capital | 2.4M | 4.6M | 9.9M | 5.1M | 8.8M | 5.1M | |
Total Current Assets | 2.6M | 4.8M | 10.6M | 6.7M | 9.4M | 5.6M | |
Accumulated Other Comprehensive Income | 0.0 | (15.4K) | 17.6K | 22.0K | 27.3K | 28.6K | |
Net Working Capital | 2.2M | 4.5M | 9.7M | 5.3M | 8.7M | 5.0M | |
Common Stock | 1.0K | 1.3K | 2.4K | 130.0 | 435.0 | 413.25 | |
Other Current Assets | 140.6K | 89.8K | 94.0K | 88.5K | 135.4K | 102.3K | |
Capital Stock | 1.0K | 1.3K | 2.4K | 130.0 | 435.0 | 818.0 |
Currently Active Assets on Macroaxis
When determining whether Hoth Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hoth Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hoth Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hoth Therapeutics Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.27) | Return On Assets (0.46) | Return On Equity (0.83) |
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.